Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report.

Tolliver BK, Desantis SM, Brown DG, Prisciandaro JJ, Brady KT.

Bipolar Disord. 2012 Feb;14(1):54-63. doi: 10.1111/j.1399-5618.2011.00973.x.

PMID:
22329472
2.

Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.

Namkoong K, Lee BO, Lee PG, Choi MJ, Lee E.

Alcohol Alcohol. 2003 Mar-Apr;38(2):135-41.

3.

Impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate.

Prisciandaro JJ, DeSantis SM, Chiuzan C, Brown DG, Brady KT, Tolliver BK.

Alcohol Clin Exp Res. 2012 Mar;36(3):490-6. doi: 10.1111/j.1530-0277.2011.01645.x. Epub 2011 Sep 20.

4.

Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.

Salloum IM, Cornelius JR, Daley DC, Kirisci L, Himmelhoch JM, Thase ME.

Arch Gen Psychiatry. 2005 Jan;62(1):37-45.

PMID:
15630071
5.

Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.

Morley KC, Teesson M, Reid SC, Sannibale C, Thomson C, Phung N, Weltman M, Bell JR, Richardson K, Haber PS.

Addiction. 2006 Oct;101(10):1451-62.

PMID:
16968347
6.

Comorbid anxiety disorders and baseline medication regimens predict clinical outcomes in individuals with co-occurring bipolar disorder and alcohol dependence: Results of a randomized controlled trial.

Prisciandaro JJ, Brown DG, Brady KT, Tolliver BK.

Psychiatry Res. 2011 Aug 15;188(3):361-5. doi: 10.1016/j.psychres.2011.04.030. Epub 2011 Jun 8.

7.

Efficacy of acamprosate for alcohol dependence in a family medicine setting in the United States: a randomized, double-blind, placebo-controlled study.

Berger L, Fisher M, Brondino M, Bohn M, Gwyther R, Longo L, Beier N, Ford A, Greco J, Garbutt JC.

Alcohol Clin Exp Res. 2013 Apr;37(4):668-74. doi: 10.1111/acer.12010. Epub 2012 Nov 7.

PMID:
23134193
9.

Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?

Richardson K, Baillie A, Reid S, Morley K, Teesson M, Sannibale C, Weltman M, Haber P.

Addiction. 2008 Jun;103(6):953-9. doi: 10.1111/j.1360-0443.2008.02215.x.

PMID:
18482418
10.
11.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
12.

A pragmatic trial of acamprosate in the treatment of alcohol dependence in primary care.

Kiritzé-Topor P, Huas D, Rosenzweig C, Comte S, Paille F, Lehert P.

Alcohol Alcohol. 2004 Nov-Dec;39(6):520-7. Epub 2004 Aug 10.

13.

Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation.

Mason BJ, Goodman AM, Chabac S, Lehert P.

J Psychiatr Res. 2006 Aug;40(5):383-93. Epub 2006 Mar 20.

PMID:
16546214
14.

Acamprosate and its efficacy in treating alcohol dependent adolescents.

Niederhofer H, Staffen W.

Eur Child Adolesc Psychiatry. 2003 Jun;12(3):144-8. Retraction in: Eur Child Adolesc Psychiatry. 2012 Dec;21(12):713.

PMID:
12768462
15.

A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence.

Brown ES, Carmody TJ, Schmitz JM, Caetano R, Adinoff B, Swann AC, John Rush A.

Alcohol Clin Exp Res. 2009 Nov;33(11):1863-9. doi: 10.1111/j.1530-0277.2009.01024.x. Epub 2009 Aug 10.

17.

Effects of acamprosate on cognition in a treatment study of patients with schizophrenia spectrum disorders and comorbid alcohol dependence.

Ralevski E, O'Brien E, Jane JS, Dean E, Dwan R, Petrakis I.

J Nerv Ment Dis. 2011 Jul;199(7):499-505. doi: 10.1097/NMD.0b013e3182214297.

PMID:
21716064
18.

Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.

Staner L, Boeijinga P, Danel T, Gendre I, Muzet M, Landron F, Luthringer R.

Alcohol Clin Exp Res. 2006 Sep;30(9):1492-9.

PMID:
16930211
19.

Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes.

Donovan DM, Anton RF, Miller WR, Longabaugh R, Hosking JD, Youngblood M; COMBINE Study Research Group.

J Stud Alcohol Drugs. 2008 Jan;69(1):5-13.

PMID:
18080059
20.

Urinary ethyl glucuronide and ethyl sulfate testing for recent drinking in alcohol-dependent outpatients treated with acamprosate or placebo.

Dahl H, Hammarberg A, Franck J, Helander A.

Alcohol Alcohol. 2011 Sep-Oct;46(5):553-7. doi: 10.1093/alcalc/agr055. Epub 2011 May 26.

Items per page

Supplemental Content

Write to the Help Desk